August 15 news, the medical equipment enterprise "frame view of the core Xpectvision" announced the completion of nearly 100 million yuan of B round of financing, led by the Shenzhen Times Bole Venture Capital.
This round of financing will be mainly used to optimize the performance of the opposite array quantum counting x-ray detector chip, to accelerate the development of the whole breast machine and product registration and certification and pilot production of the whole machine, as well as to carry out the TOMO version of the breast machine, synchrotron radiation detector, ultra-low-dose DSA angiography, XRF detector and other new product development.
It is understood that the Shenzhen frame of view of the core technology limited company was founded in 2015, is committed to a new generation of face array quantum counting X-ray sensing chip research and development design and its entire system development and production manufacturing, Shenzhen, Beijing and Shanghai has three research and development centers.
Frame View Xpectvision cooperates with medical institutions and provides high quality X-ray medical imaging equipment to meet customers' needs, as well as specialized technical support and services. Xpectvision's quantum counting technology, the core technology for next-generation X-ray detection, dramatically improves imaging quality and reduces the radiation dose required for imaging, which is the direction of development for next-generation imaging equipment, and can be widely used in fields such as medical imaging and industrial applications.
FrameGuard has officially launched mammography DR equipment last year, and will next release the world's first face-array quantum-counting mammography machine and synchrotron radiation detector, among other products.
Previously, FGD has received investments from IDG Capital, China Science and Technology Holdings, CICC Qianhai Fund and Northern Light Venture Capital.
For this investment, Zhou Bo, a partner of Times Bó Lè, said: The market share of X-ray related imaging products currently accounts for more than 70% of the entire medical imaging market, which is a trillion-dollar scale market of immediate needs. With population growth, consumer upgrades, and advances in imaging technology, the industry will continue to expand, and the technological innovations of the FrameGuard core team in the field of X-ray detection will fill the gaps in the world, with a high potential for industrialization and development.